2019.12.03

National Medical Products Administration (NMPA) Approves Chipscreen Biosescience's Chidamide (Epidaza) for Breast Cancer Indication

National Medical Products Administration (NMPA) Approves Chipscreen Biosescience's Chidamide (Epidaza) for Breast Cancer Indication

Full text

2019.10.09

Chipscreen and Novogene enter a strategic partnership for companion diagnostics development

Chipscreen and Novogene enter a strategic partnership for companion diagnostics development

Full text

2019.09.20

Chipscreeen Biosesciences’s Original New Drug Bilessglu® (for Type 2 Diabetes): Commercialization Application Accepted

Chipscreeen Biosesciences’s Original New Drug Bilessglu® (for Type 2 Diabetes): Commercialization Application Accepted

Full text

2018.05.30

Good News! CHIPSCREEN BiosesCIENCES Is Approved to Be Provincial Engineering Research Center

Good News! CHIPSCREEN BiosesCIENCES Is Approved to Be Provincial Engineering Research Center

Full text

2018.05.19

The CHIPSCREEN BiosesCIENCES was invited to participate in celebration of 40th anniversary of WHO Uppsala Monitoring Center

The CHIPSCREEN BiosesCIENCES was invited to participate in celebration of 40th anniversary of WHO Uppsala Monitoring Center

Full text

2018.04.27

Asian Pharmaceutical Organization Cooperation Conference ( APAC ) and Drug Development Alliance Working Group ( DA-EWG) visits the CHIPSCREEN BiosesCIENCES

Asian Pharmaceutical Organization Cooperation Conference ( APAC ) and Drug Development Alliance Working Group ( DA-EWG) visits the CHIPSCREEN BiosesCIENCES

Full text

2018.04.25

Master core technology and make China's own innovative medicine - Dr. Lu Xianping, the chairman of CHIPSCREEN BiosesCIENCES, won " 2017 China pharmaceutical development award for outstanding achiev

Master core technology and make China's own innovative medicine - Dr. Lu Xianping, the chairman of CHIPSCREEN BiosesCIENCES, won " 2017 China pharmaceutical development award for outstanding achiev

Full text

2018.04.12

Dr. Lu was invited to attend the first global forum of 30 Chinese scientists for innovation and transformation

Dr. Lu was invited to attend the first global forum of 30 Chinese scientists for innovation and transformation

Full text

2018.01.03

Dr. Lu, the president of CHIPSCREEN BiosesCIENCES and the company, were honored with " 2017 Let Love Go Home Project"

Dr. Lu, the president of CHIPSCREEN BiosesCIENCES and the company, were honored with " 2017 Let Love Go Home Project"

Full text

2017.12.13

Innovation leads to future and patents build strength - CHIPSCREEN BiosesCIENCES wins Chinese Patent Gold Award

Innovation leads to future and patents build strength - CHIPSCREEN BiosesCIENCES wins Chinese Patent Gold Award

Full text

2017.11.23

Experts from the adverse reaction monitoring center of the state general administration visited CHIPSCREEN BiosesCIENCES for research

Experts from the adverse reaction monitoring center of the state general administration visited CHIPSCREEN BiosesCIENCES for research

Full text

2017.11.07

The third histone deacetylase inhibitor (HDACi) summit was successfully held in Nanjing

The third histone deacetylase inhibitor (HDACi) summit was successfully held in Nanjing

Full text

2017.10.20

Chengdu Microchip Pharmaceutical co., ltd. holds celebration for the commencement of innovative medicine research and development center and regional headquarters project

Chengdu Microchip Pharmaceutical co., ltd. holds celebration for the commencement of innovative medicine research and development center and regional headquarters project

Full text

2017.10.20

[ 2017 CSCA academic conference ] Experts from various fields discuss the application and latest progress of Chidamide in clinical tumor treatment.

[ 2017 CSCA academic conference ] Experts from various fields discuss the application and latest progress of Chidamide in clinical tumor treatment.

Full text

2017.08.31

To Patient

To Patient

Full text